We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
Cap. Flow
-$707M
Cap. Flow %
-0.74%
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67

Top Buys

Rank Stock Value
1
IWB icon
iShares Russell 1000 ETF
IWB
+$99.9M
2
UBER icon
Uber
UBER
+$71M
3
AVGO icon
Broadcom
AVGO
+$36.2M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$32.6M
5
LULU icon
lululemon athletica
LULU
+$32.3M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$139M
2
AAPL icon
Apple
AAPL
+$72.7M
3
VMW
VMware, Inc
VMW
+$47.1M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$42.3M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$35.5M

Sector Composition

Rank Sector Weight
1 Technology 27.73%
2 Financials 13%
3 Healthcare 12.09%
4 Consumer Discretionary 11.32%
5 Industrials 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CURO
3726
DELISTED
CURO Group Holdings Corp.
CURO
$1.11K ﹤0.01%
1,388
– –
SCOR icon
3727
Comscore
SCOR
$113M
$1.08K ﹤0.01%
65
-1
-2% -$13
MOLN
3728
Molecular Partners
MOLN
$156M
$1.07K ﹤0.01%
269
– –
RANI icon
3729
Rani Therapeutics
RANI
$87.8M
$1.03K ﹤0.01%
312
– –
INSG icon
3730
Inseego
INSG
$87.1M
$1.03K ﹤0.01%
470
– –
ATER icon
3731
Aterian
ATER
$5.02M
$1.01K ﹤0.01%
240
– –
HYFM icon
3732
Hydrofarm Holdings
HYFM
$8.77M
$998 ﹤0.01%
109
– –
ASTR
3733
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$995 ﹤0.01%
437
+1
+0.2% +$1
MHH icon
3734
Mastech Digital
MHH
$95.7M
$994 ﹤0.01%
118
– –
FRLN
3735
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$985 ﹤0.01%
155
+40
+35% +$214
LTRN icon
3736
Lantern Pharma
LTRN
$35.5M
$975 ﹤0.01%
228
– –
API
3737
Agora
API
$351M
$920 ﹤0.01%
350
– –
TIL icon
3738
Instil Bio
TIL
$49.4M
$868 ﹤0.01%
114
-1
-0.9% -$7
SLAI
3739
DELISTED
SOLAI Ltd ADS
SLAI
$846 ﹤0.01%
24
– –
BZFD icon
3740
BuzzFeed
BZFD
$94.1M
$839 ﹤0.01%
839
– –
EMKR
3741
DELISTED
Emcore Corp
EMKR
$821 ﹤0.01%
168
– –
RGS icon
3742
Regis Corp
RGS
$71.9M
$803 ﹤0.01%
85
– –
NXTC icon
3743
NextCure
NXTC
$22.7M
$801 ﹤0.01%
59
– –
STN icon
3744
Stantec
STN
$8.34B
$801 ﹤0.01%
10
– –
TRIB
3745
Trinity Biotech
TRIB
$7.86M
$797 ﹤0.01%
12
– –
SOHO
3746
DELISTED
Sotherly Hotels
SOHO
$794 ﹤0.01%
533
– –
PASG icon
3747
Passage Bio
PASG
$14.1M
$790 ﹤0.01%
39
– –
OMIC
3748
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$764 ﹤0.01%
55
– –
VRN
3749
DELISTED
Veren
VRN
$762 ﹤0.01%
110
– –
NEUP
3750
Neuphoria Therapeutics
NEUP
$21.1M
$757 ﹤0.01%
42
– –
148 149
150
151 152

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
  • RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
  • RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
  • RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
  • RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.

Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.